Source: International Journal of Stroke. Unidades: FM, HU, IME
Subjects: PAÍSES EM DESENVOLVIMENTO, ACIDENTE VASCULAR CEREBRAL, NEUROLOGIA, FATORES DE RISCO, ESTATÍSTICA APLICADA
ABNT
GOULART, Alessandra Carvalho; OLMOS, Rodrigo Diaz; SANTOS, Itamar S; et al. EXPRESS: the impact of atrial fibrillation and long-term oral anticoagulant use on all-cause and cardiovascular mortality: A 12-year evaluation of the prospective Brazilian Study of Stroke Mortality and Morbidity (EMMA). International Journal of Stroke, London, SAGE Publications, 2021. Disponível em: < https://doi.org/10.1177/1747493021995592 > DOI: 10.1177/1747493021995592.APA
Goulart, A. C., Olmos, R. D., Santos, I. S., Tunes, G., Alencar, A. P., Thomas, G. N., et al. (2021). EXPRESS: the impact of atrial fibrillation and long-term oral anticoagulant use on all-cause and cardiovascular mortality: A 12-year evaluation of the prospective Brazilian Study of Stroke Mortality and Morbidity (EMMA). International Journal of Stroke. doi:10.1177/1747493021995592NLM
Goulart AC, Olmos RD, Santos IS, Tunes G, Alencar AP, Thomas GN, Lip G, Lotufo PA, Bensenor IJM. EXPRESS: the impact of atrial fibrillation and long-term oral anticoagulant use on all-cause and cardiovascular mortality: A 12-year evaluation of the prospective Brazilian Study of Stroke Mortality and Morbidity (EMMA) [Internet]. International Journal of Stroke. 2021 ;Available from: https://doi.org/10.1177/1747493021995592Vancouver
Goulart AC, Olmos RD, Santos IS, Tunes G, Alencar AP, Thomas GN, Lip G, Lotufo PA, Bensenor IJM. EXPRESS: the impact of atrial fibrillation and long-term oral anticoagulant use on all-cause and cardiovascular mortality: A 12-year evaluation of the prospective Brazilian Study of Stroke Mortality and Morbidity (EMMA) [Internet]. International Journal of Stroke. 2021 ;Available from: https://doi.org/10.1177/1747493021995592